Log In
Print this Print this

lefitolimod (MGN1703)

  Manage Alerts
Collapse Summary General Information
Company Mologen AG
DescriptionToll-like receptor 9 (TLR9) agonist based on double Stem Loop Immunomodulator (dSLIM) technology
Molecular Target Toll-like receptor 9 (TLR9)
Mechanism of ActionImmune modulation; Toll-like receptor 9 (TLR9) agonist
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today